201 related articles for article (PubMed ID: 27256357)
21. Ebselen effects on MPTP-induced neurotoxicity.
Dhanasekaran M; Uthayathas S; Karuppagounder SS; Parameshwaran K; Suppiramaniam V; Ebadi M; Brown-Borg HM
Brain Res; 2006 Nov; 1118(1):251-4. PubMed ID: 16956591
[TBL] [Abstract][Full Text] [Related]
22. The effects of medication and current mood upon facial emotion recognition: findings from a large bipolar disorder cohort study.
Bilderbeck AC; Atkinson LZ; Geddes JR; Goodwin GM; Harmer CJ
J Psychopharmacol; 2017 Mar; 31(3):320-326. PubMed ID: 27678089
[TBL] [Abstract][Full Text] [Related]
23. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.
Yamaguchi T; Sano K; Takakura K; Saito I; Shinohara Y; Asano T; Yasuhara H
Stroke; 1998 Jan; 29(1):12-7. PubMed ID: 9445321
[TBL] [Abstract][Full Text] [Related]
24. A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease.
Martini F; Rosa SG; Klann IP; Fulco BCW; Carvalho FB; Rahmeier FL; Fernandes MC; Nogueira CW
J Psychiatr Res; 2019 Feb; 109():107-117. PubMed ID: 30521994
[TBL] [Abstract][Full Text] [Related]
25. Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons.
Porciúncula LO; Rocha JB; Boeck CR; Vendite D; Souza DO
Neurosci Lett; 2001 Feb; 299(3):217-20. PubMed ID: 11165774
[TBL] [Abstract][Full Text] [Related]
26. Ebselen inhibits the activity of acetylcholinesterase globular isoform G4 in vitro and attenuates scopolamine-induced amnesia in mice.
Martini F; Pesarico AP; Brüning CA; Zeni G; Nogueira CW
J Cell Biochem; 2018 Jul; 119(7):5598-5608. PubMed ID: 29405440
[TBL] [Abstract][Full Text] [Related]
27. The neuroprotectant ebselen inhibits oxidative DNA damage induced by dopamine in the presence of copper ions.
Li Y; Cao Z
Neurosci Lett; 2002 Sep; 330(1):69-73. PubMed ID: 12213637
[TBL] [Abstract][Full Text] [Related]
28. Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
Billack B; Santoro M; Lau-Cam C
Microb Drug Resist; 2009 Jun; 15(2):77-83. PubMed ID: 19432523
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats.
Unsal C; Oran M; Albayrak Y; Aktas C; Erboga M; Topcu B; Uygur R; Tulubas F; Yanartas O; Ates O; Ozen OA
Toxicol Ind Health; 2016 Apr; 32(4):730-40. PubMed ID: 24231787
[TBL] [Abstract][Full Text] [Related]
30. Investigating the effects of ebselen, a potential new lithium mimetic, on glutamate transmission.
Mota F; Sementa T; Taddei C; Moses N; Bordoloi J; Hader S; Eykyn T; Cash D; Turkheimer F; Veronese M; Singh N
Synapse; 2020 Jul; 74(7):e22151. PubMed ID: 32056277
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial.
Kil J; Lobarinas E; Spankovich C; Griffiths SK; Antonelli PJ; Lynch ED; Le Prell CG
Lancet; 2017 Sep; 390(10098):969-979. PubMed ID: 28716314
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage.
Saito I; Asano T; Sano K; Takakura K; Abe H; Yoshimoto T; Kikuchi H; Ohta T; Ishibashi S
Neurosurgery; 1998 Feb; 42(2):269-77; discussion 277-8. PubMed ID: 9482177
[TBL] [Abstract][Full Text] [Related]
33. Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice.
Namura S; Nagata I; Takami S; Masayasu H; Kikuchi H
Stroke; 2001 Aug; 32(8):1906-11. PubMed ID: 11486124
[TBL] [Abstract][Full Text] [Related]
34. Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trial.
Beckman JA; Goldfine AB; Leopold JA; Creager MA
Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1431-H1436. PubMed ID: 27765750
[TBL] [Abstract][Full Text] [Related]
35. Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic.
Ren X; Zou L; Lu J; Holmgren A
Free Radic Biol Med; 2018 Nov; 127():238-247. PubMed ID: 29807162
[TBL] [Abstract][Full Text] [Related]
36. Early effects of duloxetine on emotion recognition in healthy volunteers.
Bamford S; Penton-Voak I; Pinkney V; Baldwin DS; Munafò MR; Garner M
J Psychopharmacol; 2015 May; 29(5):634-41. PubMed ID: 25759400
[TBL] [Abstract][Full Text] [Related]
37. Inhibition by ebselen on nitric oxide mediated relaxations in the rat anococcygeus muscle.
Che Y; Rand MJ; Li CG
Eur J Pharmacol; 2003 Feb; 462(1-3):161-8. PubMed ID: 12591109
[TBL] [Abstract][Full Text] [Related]
38. Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione.
Schewe C; Schewe T; Wendel A
Biochem Pharmacol; 1994 Jul; 48(1):65-74. PubMed ID: 8043032
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effects of ebselen following forebrain ischemia: involvement of glutamate and nitric oxide.
Koizumi H; Fujisawa H; Suehiro E; Shirao S; Suzuki M
Neurol Med Chir (Tokyo); 2011; 51(5):337-43. PubMed ID: 21613757
[TBL] [Abstract][Full Text] [Related]
40. The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site.
Herin GA; Du S; Aizenman E
J Neurochem; 2001 Sep; 78(6):1307-14. PubMed ID: 11579139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
